WHJ Volume 14 Issue 2 Articles
Showing all 9 results
-
Editorial 1. Can Nonpharmacological Agents Decrease Cardiovascular Diseases without Decreasing Serum Cholesterol?
$50.00 – $75.00 Select options -
Personalized Medicine: A Novel Approach for the Management of Hypertension
$50.00 – $75.00 Select options -
Impact of Time Delay on Thrombus Burden and TIMI-Flow in ST Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention
$50.00 – $75.00 Select options -
Glucagon Like Peptide Agonists as Therapy for Treatment of Cardiometabolic Diseases
$50.00 – $75.00 Select options -
Incidental Findings of Brugada Syndrome Type-1 and Epsilon-Like Pattern in Otherwise Healthy Man: A Case Report
$50.00 – $75.00 Select options -
The Use of Statins in Primary Prevention of Cardiovascular Disease: Benefits versus Risks
$50.00 – $75.00 Select options -
Usage of Serum Anion Gap to Predict in-Hospital and 1-Year All-Cause Mortality in Cardiac Care Unit Patients
$50.00 – $75.00 Select options -
View Point. Glucagon Like Peptide-1 Levels and Its Variability
$50.00 – $75.00 Select options -
Editorial 2. Can Twin Incretins Decrease Blood Glucose and Blood Lipids?
$50.00 – $75.00 Select options
Showing all 9 results
